Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/10/2013 | 02:09pm CEST

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
[email protected]
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
12:06a HONDA MOTOR : F1 champion Alonso swigs milk at Indy, just not as winner
05/28 FICO Grand Panjandrum David Howe Applauds Credit Karma for Removing Ad
05/28 HONDA MOTOR : validates engine trouble by winning Indianapolis 500
05/28 EASTMAN KODAK : Kodak Congratulates Sofia Coppola for winning Best Director prize at Cannes Film Festival for “The Beguiled”
05/28 BUFFETT LOVES THESE 5 STOCKS : Apple (AAPL), Coca-Cola (KO) and 3 Other
05/28 UNITED CONTINENTAL : US 'might' expand laptop ban to all flights
05/28 ARCELORMITTAL'S BRUNO RIBO : We could produce at Galati whole steel amount for BRUA pipeline
05/28 EURONET WORLDWIDE : aims to inject EGP 400m in Egypt by end of 2018
05/28 BOMBARDIER : Jambojet gets licence to fly international destinations
05/28 PRUDENTIAL : in race to settle Shield Assurance claims
Latest news
Advertisement
Hot News 
8.47%SPIRAX SARCO ENGINEERING : Sarco to buy thermal tech firm Chromalox for $415 million
10.46%RESTAURANT : gets off to stronger start in 2017 amid turnaround
-4.04%BA and Iberia plan third-party booking surcharge, Amadeus shares hit
3.25%Fosun, others eye Australia's Origin Energy gas assets worth $1.5 billion - sources
-4.92%SUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
Most Read News
06:06p HONDA MOTOR : F1 champion Alonso swigs milk at Indy, just not as winner
04:18p Russia squares up to Boeing, Airbus with maiden jet flight
05/27 INTERNATIONAL CONSOLIDATED AIRLNS : British Airways outage has not canceled RDU flight to London; fliers should check status
10:05a SUPPLY PROBLEMS HIT PRODUCTION AT BMW : Focus
05/27 GENERAL MOTORS : Detroit Free Press Susan Tompor column
Most recommended articles
05/22 NOBLE : shares tumble after S&P ratings downgrade
04:48p Russia squares up to Boeing, Airbus with maiden jet flight
03:20p Gazprom executive to meet EU antitrust chief, may have to improve concessions
10:05a SUPPLY PROBLEMS HIT PRODUCTION AT BMW : Focus
08:47aDJFor Hotels, There's No Room Left for Online Travel Agencies